Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
- Attruby is the first and only approved product with a label…
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on…
2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries
AMSTERDAM, Nov. 19, 2024 /PRNewswire/ -- The 2024 Access to Medicine Index…
James Dyson Award announces its 2024 global winners: Hair-loss prevention device for chemotherapy patients and Sustainable ‘maple seed’ weather balloon
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its…
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…
James Dyson Award announces its 2024 global winners: Hair-loss prevention device for chemotherapy patients and Sustainable ‘maple seed’ weather balloon
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its…
James Dyson Award announces its 2024 global winners: Hair-loss prevention device for chemotherapy patients and Sustainable ‘maple seed’ weather balloon
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its…
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…
James Dyson Award announces its 2024 global winners: Hair-loss prevention device for chemotherapy patients and Sustainable ‘maple seed’ weather balloon
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its…
James Dyson Award announces its 2024 global winners: Hair-loss prevention device for chemotherapy patients and Sustainable ‘maple seed’ weather balloon
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its…